CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Betamethasone

倍他米松 杂质对照品Betamethasone Impurities

EP47 个杂质条目47 impurity entries

本页汇总 倍他米松 的 47 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 47 impurity reference standards of Betamethasone with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 倍他米松(Betamethasone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a RP-UPLC method for the determination of betamethasone dipropionate impurities in topical formulations using a multivariate central composite design
    Analytical methods : advancing methods and applications · 2021 · Muchakayala SK et al.  ·  PMID 34338254  ·  DOI
  2. 杂质研究Impurity studiesAn RP-HPLC Method for the Stability-Indicating Analysis of Impurities of Both Fusidic Acid and Betamethasone-17-Valerate in a Semi-Solid Pharmaceutical Dosage Form
    Journal of chromatographic science · 2015 · Byrne J et al.  ·  PMID 25896658  ·  DOI
  3. 杂质研究Impurity studiesA fast, validated UPLC method coupled with PDA-QDa detectors for impurity profiling in betamethasone acetate and betamethasone phosphate injectable suspension and isolation, identification, characterization of two thermal impurities
    Annales pharmaceutiques francaises · 2022 · Murali Krishnam Raju P et al.  ·  PMID 35489418  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisDivergent Chemo- and Biocatalytic Route to 16β-Methylcorticoids: Asymmetric Synthesis of Betamethasone Dipropionate, Clobetasol Propionate, and Beclomethasone Dipropionate
    Angewandte Chemie (International ed. in English) · 2024 · Wei J et al.  ·  PMID 37994255  ·  DOI
  • 合成方法SynthesisEffect of betamethasone-17-valerate on synthesis of collagen and prolyl hydroxylase activity in chick embryo tendon cells
    Biochemical pharmacology · 1977 · Oikarinen A  ·  PMID 193518  ·  DOI

倍他米松 —— 原料药与杂质对照品Betamethasone — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Betamethasone Impurity 3 (Betamethasone EP Impurity C) structure
EPC
倍他米松杂质3 (倍他米松EP杂质C)Betamethasone Impurity 3 (Betamethasone EP Impurity C)
Betamethasone Impurity 3 (Betamethasone EP Impurity C)
CAS No.13504-15-9
Chemical FormulaC22H28O4
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 20 (Betamethasone Acetate EP Impurity C)(Betamethasone 11,21-Diacetate) structure
EPC
倍他米松杂质20 (醋酸倍他米松EP杂质C)(倍他米松-11,21-二醋酸)Betamethasone Impurity 20 (Betamethasone Acetate EP Impurity C)(Betamethasone 11,21-Diacetate)
Betamethasone Impurity 20 (Betamethasone Acetate EP Impurity C)(Betamethasone 11,21-Diacetate)
CAS No.330157-05-6
Chemical FormulaC26H33FO7
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 4 (Betamethasone EP Impurity D) structure
EPD
倍他米松杂质4 (倍他米松EP杂质D)Betamethasone Impurity 4 (Betamethasone EP Impurity D)
Betamethasone Impurity 4 (Betamethasone EP Impurity D)
CAS No.52619-05-3
Chemical FormulaC25H33FO7
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 21 (Betamethasone Acetate EP Impurity D) structure
EPD
倍他米松杂质21 (醋酸倍他米松EP杂质D)Betamethasone Impurity 21 (Betamethasone Acetate EP Impurity D)
Betamethasone Impurity 21 (Betamethasone Acetate EP Impurity D)
CAS No.912-38-9
Chemical FormulaC24H30O6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 5 (Betamethasone EP Impurity E) structure
EPE
倍他米松杂质5 (倍他米松EP杂质E)Betamethasone Impurity 5 (Betamethasone EP Impurity E)
Betamethasone Impurity 5 (Betamethasone EP Impurity E)
CAS No.981-34-0
Chemical FormulaC22H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 6 (Betamethasone EP Impurity F) structure
EPF
倍他米松杂质6 (倍他米松EP杂质F)Betamethasone Impurity 6 (Betamethasone EP Impurity F)
Betamethasone Impurity 6 (Betamethasone EP Impurity F)
CAS No.330157-04-5
Chemical FormulaC22H28O4
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 7 (Betamethasone EP Impurity G) structure
EPG
倍他米松杂质7 (倍他米松EP杂质G)Betamethasone Impurity 7 (Betamethasone EP Impurity G)
Betamethasone Impurity 7 (Betamethasone EP Impurity G)
CAS No.85700-75-0
Chemical FormulaC22H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 8 (Betamethasone EP Impurity H) structure
EPH
倍他米松杂质8 (倍他米松EP杂质H)Betamethasone Impurity 8 (Betamethasone EP Impurity H)
Betamethasone Impurity 8 (Betamethasone EP Impurity H)
CAS No.185613-71-2
Chemical FormulaC22H29FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 9 (Betamethasone EP Impurity I) structure
EPI
倍他米松杂质9 (倍他米松EP杂质I)Betamethasone Impurity 9 (Betamethasone EP Impurity I)
Betamethasone Impurity 9 (Betamethasone EP Impurity I)
CAS No.185613-69-8
Chemical FormulaC22H29FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 10 (Betamethasone EP Impurity J) structure
EPJ
倍他米松杂质10 (倍他米松EP杂质J)Betamethasone Impurity 10 (Betamethasone EP Impurity J)
Betamethasone Impurity 10 (Betamethasone EP Impurity J)
CAS No.18383-24-9
Chemical FormulaC22H30O4
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 11 structure
11
倍他米松杂质11Betamethasone Impurity 11
Betamethasone Impurity 11
CAS No.338-95-4
Chemical FormulaC21H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 12 structure
12
倍他米松杂质12Betamethasone Impurity 12
Betamethasone Impurity 12
CAS No.560-34-9
Chemical FormulaC22H31FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 13 structure
13
倍他米松杂质13Betamethasone Impurity 13
Betamethasone Impurity 13
CAS No.61558-12-1
Chemical FormulaC22H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 14 structure
14
倍他米松杂质14Betamethasone Impurity 14
Betamethasone Impurity 14
CAS No.987-24-6
Chemical FormulaC24H31FO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 15 structure
15
倍他米松杂质15Betamethasone Impurity 15
Betamethasone Impurity 15
CAS No.37926-75-3
Chemical FormulaC21H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 16 structure
16
倍他米松杂质16Betamethasone Impurity 16
Betamethasone Impurity 16
CAS No.3109-01-1
Chemical FormulaC20H25FO3
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 17 structure
17
倍他米松杂质17Betamethasone Impurity 17
Betamethasone Impurity 17
CAS No.52647-06-0
Chemical FormulaC22H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 18 structure
18
倍他米松杂质18Betamethasone Impurity 18
Betamethasone Impurity 18
CAS No.52647-07-1
Chemical FormulaC22H27FO4
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 19 structure
19
倍他米松杂质19Betamethasone Impurity 19
Betamethasone Impurity 19
CAS No.1203841-38-6
Chemical FormulaC22H28BrFO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 22 structure
22
倍他米松杂质22Betamethasone Impurity 22
Betamethasone Impurity 22
CAS No.312-93-6
Chemical FormulaC22H30FO8P
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 24 structure
24
倍他米松杂质24Betamethasone Impurity 24
Betamethasone Impurity 24
CAS No.21720-47-8
Chemical FormulaC23H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 25 structure
25
倍他米松杂质25Betamethasone Impurity 25
Betamethasone Impurity 25
CAS No.25122-45-6
Chemical FormulaC24H30ClFO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 26 structure
26
倍他米松杂质26Betamethasone Impurity 26
Betamethasone Impurity 26
CAS No.5534-01-0
Chemical FormulaC28H37FO7
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 27 structure
27
倍他米松杂质27Betamethasone Impurity 27
Betamethasone Impurity 27
CAS No.5534-02-1
Chemical FormulaC29H39FO7
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 35 structure
35
倍他米松杂质35Betamethasone Impurity 35
Betamethasone Impurity 35
CAS No.1249-19-0
Chemical FormulaC22H29FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 36 structure
36
倍他米松杂质36Betamethasone Impurity 36
Betamethasone Impurity 36
CAS No.22298-29-9
Chemical FormulaC29H33FO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 38 structure
38
倍他米松杂质38Betamethasone Impurity 38
Betamethasone Impurity 38
CAS No.154713-07-2
Chemical FormulaC27H37FO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 41 structure
41
倍他米松杂质41Betamethasone Impurity 41
Betamethasone Impurity 41
CAS No.90039-90-0
Chemical FormulaC20H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 47 structure
47
倍他米松杂质47Betamethasone Impurity 47
Betamethasone Impurity 47
CAS No.116846-77-6
Chemical FormulaC22H27ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 48 structure
48
倍他米松杂质48Betamethasone Impurity 48
Betamethasone Impurity 48
CAS No.97168-90-6
Chemical FormulaC24H31BrO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 50 (21-Desacetyl Amcinonide) structure
50
倍他米松杂质50 (21-去乙酰安西奈德)Betamethasone Impurity 50 (21-Desacetyl Amcinonide)
Betamethasone Impurity 50 (21-Desacetyl Amcinonide)
CAS No.55646-99-6
Chemical FormulaC26H33FO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 59 structure
59
倍他米松杂质59Betamethasone Impurity 59
Betamethasone Impurity 59
CAS No.5534-12-3
Chemical FormulaC24H31FO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 61 structure
61
倍他米松杂质61Betamethasone Impurity 61
Betamethasone Impurity 61
CAS No.13796-49-1
Chemical FormulaC24H31BrO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 62 structure
62
倍他米松杂质62Betamethasone Impurity 62
Betamethasone Impurity 62
CAS No.1257544-85-6
Chemical FormulaC23H29FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 65 Disodium Salt structure
65
倍他米松杂质65 二钠盐Betamethasone Impurity 65 Disodium Salt
Betamethasone Impurity 65 Disodium Salt
CAS No.1215720-27-6
Chemical FormulaC22H28FO8P2-·2Na+
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 65 structure
65
倍他米松杂质65Betamethasone Impurity 65
Betamethasone Impurity 65
CAS No.1215899-28-7
Chemical FormulaC22H30FO8P
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 67 structure
67
倍他米松杂质67Betamethasone Impurity 67
Betamethasone Impurity 67
CAS No.96789-15-0
Chemical FormulaC20H24O2
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 68 structure
68
倍他米松杂质68Betamethasone Impurity 68
Betamethasone Impurity 68
CAS No.98574-03-9
Chemical FormulaC22H26O2
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 69 structure
69
倍他米松杂质69Betamethasone Impurity 69
Betamethasone Impurity 69
CAS No.790165-38-7
Chemical FormulaC22H30ClO8P
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 69 Disodium Salt structure
69
倍他米松杂质69 二钠盐Betamethasone Impurity 69 Disodium Salt
Betamethasone Impurity 69 Disodium Salt
CAS No.94135-39-4
Chemical FormulaC22H28ClO8P2-·2Na+
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 74 structure
74
倍他米松杂质74Betamethasone Impurity 74
Betamethasone Impurity 74
CAS No.37414-01-0
Chemical FormulaC22H27FI2O4
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 79 structure
79
倍他米松杂质79Betamethasone Impurity 79
Betamethasone Impurity 79
CAS No.1184871-60-0
Chemical FormulaC22H29FO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 84 structure
84
倍他米松杂质84Betamethasone Impurity 84
Betamethasone Impurity 84
CAS No.1257544-84-5
Chemical FormulaC22H27FO5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 86 structure
86
倍他米松杂质86Betamethasone Impurity 86
Betamethasone Impurity 86
CAS No.114488-14-1
Chemical FormulaC22H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 88 (Betamethasone 17-Butyrate) structure
88
倍他米松杂质88 (倍他米松17-丁酸)Betamethasone Impurity 88 (Betamethasone 17-Butyrate)
Betamethasone Impurity 88 (Betamethasone 17-Butyrate)
CAS No.5534-14-5
Chemical FormulaC26H35FO6
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 89 structure
89
倍他米松杂质89Betamethasone Impurity 89
Betamethasone Impurity 89
CAS No.5514-77-2
Chemical FormulaC26H33FO7
Purity>95%询价On request
10mg25mg50mg100mg
Betamethasone Impurity 90 structure
90
倍他米松杂质90Betamethasone Impurity 90
Betamethasone Impurity 90
CAS No.123013-29-6
Chemical FormulaC27H37FO6
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

倍他米松 —— 研究文献与合成路线Betamethasone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 倍他米松 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Betamethasone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Forced degradation of betamethasone sodium phosphate under solid state: Formation, characterization, and mechanistic study of all four 17,20-diastereomers of betamethasone 17-deoxy-20-hydroxy-21-oic acid
    Li M, Wang X, Chen B, et al. · Journal of pharmaceutical sciences · 2009 · 被引 14cited 14
  2. Simultaneous Estimation of Apremilast and Betamethasone Dipropionate in Microsponge-Based Topical Formulation using a Stability Indicating RP-HPLC Method: A Quality-by-Design Approach
    Mullick P, Mutalik SP, Hegde AR, et al. · Journal of chromatographic science · 2021 · 被引 7cited 7
  3. An RP-HPLC Method for the Stability-Indicating Analysis of Impurities of Both Fusidic Acid and Betamethasone-17-Valerate in a Semi-Solid Pharmaceutical Dosage Form
    Byrne J, Velasco-Torrijos T, Reinhardt R · Journal of chromatographic science · 2015 · 被引 5cited 5
  4. Development and validation of a RP-UPLC method for the determination of betamethasone dipropionate impurities in topical formulations using a multivariate central composite design
    Muchakayala SK, Pavithra K, Katari NK, et al. · Analytical methods : advancing methods and applications · 2021 · 被引 19cited 19
  5. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate
    Lin M, Li M, Buevich AV, et al. · Journal of pharmaceutical and biomedical analysis · 2009 · 被引 13cited 13
  6. Kinetics of thermal degradation of betamethasone valerate and betamethasone dipropionate in different media
    Khattak SU, Sheikh D, Ahmad I, et al. · Indian journal of pharmaceutical sciences · 2012 · 被引 10cited 10

合成与制备工艺专利Synthesis & process patents

  1. Preparation method of betamethasone dipropionate micro-particle
    JUAN LI, JUNSHENG LIU, FEI XU · 公开号 CN101849910CN101849910 · 2010
  2. SKIN-CARE PREPARATIONS CONTAINING MUPIROCIN AND BETAMETHASONE DIPROPIONATE
    AHUMADA AYALA FERNANDO · 公开号 US2010063015US2010063015 · 2010
  3. Method for preparing betamethasone and series products thereof
    LEI DENG, SICHUN HE, XIAOYUN JIANG, JISHENG CHEN · 公开号 CN101397319CN101397319 · 2009
  4. A MEDICINAL FUSIDIC ACID CREAM MADE USING SIDIUM FUSIDATE AND INCORPORATING A BIOPOLYMER AND BETAMETHASONE, AND A PROCESS TO MAKE IT
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, GHOSH KAUSIK, et al. · 公开号 WO2011101828WO2011101828 · 2011
  5. A MEDICINAL FUSIDIC ACID CREAM MADE USING SODIUM FUSIDATE AND INCORPORATING BIOPOLYMER, BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE AND A PROCESS TO MAKE IT
    VANANGAMUDI SULUR SUBRAMANIAM, SRINIVASAN MADHAVAN, CHULLIEL NEELAKANDAN NARAYANAN, SELVARAJ BALKRISHNANA, et al. · 公开号 WO2012017369WO2012017369 · 2012

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

倍他米松 杂质谱研究要点Betamethasone — impurity profiling notes

下面这些是拿到 倍他米松 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Betamethasone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances